The Pharmaceutical Market: China
| Publication Date | July 2008 |
|---|---|
| Publisher | Espicom |
| Product Type | Report |
| Pages | 110 |
| ISBN Number | not applicable |
| Product Code | ESP00225 |
Summary
Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data.Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy.The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Content
- INTRODUCTION
- REGULATORY ENVIRONMENT
- Pharmaceutical Registration
- Revised Provisions for Drug Registration
- State Food and Drug Administration (SFDA)
- Department of Drug Registration
- Department of Drug Safety & Inspection
- Department of Drug Market Compliance
- Drug Classification
- Biotech regulation
- New Regulatory Legislation
- 2001 DAL Amendments
- The Drug Import Regulation
- GMP Regulations
- Pharmaceutical Registration/Drug Approval Process
- Clinical trials
- Quality test
- Certification
- Packaging Regulations
- Post-market Surveillance
- Licences of 160 drug firms revoked in 2006
- Pharmaceutical Advertising
- Patent Protection & Intellectual Property Rights
- Administrative Protection
- Pharmaceutical Pricing and Reimbursement
- Pricing
- Pricing Sector Developments
- Provincial governments
- Reimbursement Lists
- Pharmaceutical Registration
- DISTRIBUTION CHANNELS
- Distribution System Reform
- Internet Pharmaceutical Distribution
- Pharmaceutical retail
- Chindex
- Hainan Kangtong Pharmaceutical Co Ltd
- Hunan Provincial Medicines & Health Products Import & Export Corp
- Shandong Medicines & Health Products Import & Export Corp
- Simcere Pharmaceutical Group
- Sincer Pharmchem Ltd
- Sinochem Jiangsu Suzhou Import Export Corp
- Tianjin Medicines & Health Products Import & Export Corp
- Aida Pharmaceuticals
- Anhui Anke Biotech
- Beijing Four Ring Biopharmaceutical Co. Ltd
- Changzhou Siyao Pharmaceuticals Co. Ltd
- China Pharmaceutical Enterprise
- Dragon Pharmaceuticals
- Fuzhou Antibiotic Group Corp
- Haizhou Pharmaceutical Co. Ltd
- Harbin Pharmaceutical Group Co. Ltd
- Heshuo Ephedrine Factory
- Huazhong Pharmaceutical Co. Ltd
- Jiangsu Jiangan Pharmaceutical Corp Ltd
- Jiuyuan
- Livzon (Group) Libao Biochemical & Pharmaceutical Co Ltd
- Ningbo Jierfu Pharmaceutical Co Ltd
- North China Pharmaceutical Huasheng Co. Ltd
- Shenyang Sunshine Pharmaceutical Co Ltd
- Shenzhen Kexing Biotech
- Shenzhen Zhijun Pharmaceutical Company
- Shenzhen Taitai Pharmaceutical Industry (Taitai)
- Sinovac Biotech Ltd
- Wenzhou Pharmaceutical Factory
- Xiamen No.2 Pharmaceutical Factory
- Xinhua Pharma
- Yiyuan Pharmaceutical Co Ltd
- Zhejiang Jinhua Lixin Fine Chemicals Co Ltd
- Allergan
- Antibioticos
- Astellas Pharma
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson
- Laboratories Servier
- Merck KGaA
- Merck Sharp & Dohme
- Novartis
- Novo Nordisk
- Pfizer
- Ranbaxy
- Rexim SA (Degussa)
- Roche
- Sanofi-Aventis
- Schering-Plough
- Takeda
- Tanabe
- Watson
- Wyeth
- SFDA initiatives
- Zhangjiang Hi-Tech Park
- Beijing Union Pharmaceutical Factory
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















